Myeloma | Tumor

CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.

Closer to a Cure for Myeloma

May 10th 2018

In pretreated multiple myeloma, experimental CAR-T cell immunotherapy offers the potential for long-term — and possibly even permanent — remission.

FDA Approves Darzalex Combination for Newly Diagnosed Multiple Myeloma

May 8th 2018

The Food and Drug Administration (FDA) granted approval to Darzalex (daratumumab) in combination with Velcade (bortezomib), melphalan and prednisone – also known as VMP – for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT).

Treatment Options Expanding for Transplant-Ineligible Patients with Myeloma

May 2nd 2018

One expert discusses current standard-of-care regimens as well as new combinations on the horizon for patients with myeloma who are not eligible to receive a stem cell transplant.

New Study Finds More Cancer Risks in Firefighters Exposed to 9/11 Disaster

April 27th 2018

Nearly 17 years after the terror attack, researchers examine World Trade Center environmental factors and cases of multiple myeloma.

Treating Relapsed Myeloma Is Not One-Size-Fits-All

April 20th 2018

There are a number of different treatment options for patients with relapsed myeloma, and it is important that patients and providers dicuss health history to determine which one is best.

Minorities and Myeloma: One Advocate's Story

April 19th 2018

In this week's episode of CURE Talks Cancer, we spoke with Kimberly Alexander, who became an advocate for minority health after her husband was diagnosed with multiple myeloma.

New and Upcoming Treatments Are Vastly Changing the Myeloma Space

April 3rd 2018

Although the amount of treatment options for the frontline setting of multiple myeloma may be limited, extensive research is helping these efforts along.

Screening At-Risk Populations Can Decrease Myeloma Deaths

April 3rd 2018

Simply knowing who to screen, and when, could reduce myeloma-related mortality rates, according to recent research.

African American Caregivers Face a Greater Burden and Need Accessible Information and Support

March 28th 2018

When I recited my wedding vows to Eli in 1995, I never expected to be his caregiver. At the time, Eli was seemingly at the peak of good health and in the middle of his nine-year career as a professional linebacker.

Looking Ahead in Multiple Myeloma

March 20th 2018

Options Following Recurrence in Multiple Myeloma

March 20th 2018

Multiple Myeloma Treatments: Quality-of-Life Considerations

March 20th 2018

Monitoring for Disease Recurrence in Multiple Myeloma

March 20th 2018

Decisions Regarding Maintenance Therapy in Multiple Myeloma

March 20th 2018

About Stem Cell Transplantation in Multiple Myeloma

March 20th 2018

Treatment Approach in Multiple Myeloma

March 20th 2018

Determining Staging and Risk in Multiple Myeloma

March 20th 2018

Learning You Have Multiple Myeloma

March 20th 2018

Multiple Myeloma: Aurora's Story

March 20th 2018

The IMF Spreads Awareness Through Myeloma Action Month

March 13th 2018

The International Myeloma Foundation declared March to be Myeloma Action Month to help raise awareness about the disease.

Distinguishing Myeloma from Smoldering Myeloma

March 13th 2018

The definition of smoldering myeloma was reworked in recent years.

Cognitive Impairments May Affect Survival in Older Patients with Blood Cancer

March 8th 2018

Cognitive dysfunction among geriatric patients with blood cancers – such as multiple myeloma, leukemia and lymphoma – is not only prevalent, but may also impact long-term survival.

Distress Score Could Shape Myeloma Treatment Interventions

March 6th 2018

While recent breakthroughs have led to more treatment options for multiple myeloma, patients are also experiencing new side effects, stressful financial issues and psychological burdens. In turn, recent research found that this increased distress may actually have negative implications for patient outcomes.

Better Outcomes in High-Risk Multiple Myeloma

March 2nd 2018

Experts focus on genetic abnormalities to advance cancer care.

Stars Shine at Multiple Myeloma Fundraiser

February 27th 2018

The annual Los Angeles event was launched 11 years ago in honor of Romano’s Everybody Loves Raymond costar, Peter Boyle, who died of the rare blood cancer multiple myeloma in 2006.

Stem Cell Transplantation Remains Standard of Care in Multiple Myeloma

February 19th 2018

Patients with multiple myeloma who are eligible for stem cell transplantation should still be considered for high-dose therapy (HDT) even in the novel agent era, according to the authors of a study recently published in the Journal of the American Medical Association Oncology.

Myeloma Precursor May Cause Disease Progression, Even 30 Years Later

February 19th 2018

An abnormal protein found in the blood – called monoclonal gammopathy of undetermined significance (MGUS) – may lead to multiple myeloma progression, even after 30 years of disease stability, according to study results published in the New England Journal of Medicine.

The History Behind the Development of CAR-T Cell Therapy

February 8th 2018

These advancements are changing the way many cancers are being treated.

Exploring Unanswered Questions on CAR-T Cell Therapy in Myeloma

January 29th 2018

The success of CAR- (chimeric antigen receptor) T cell therapy is causing landmark change in the way that patients with multiple myeloma are being treated, but more research needs to be done to better understand the role that these agents will play.

Giving Patients Autonomy During Difficult Conversations

January 27th 2018

A new patient-reported outcomes tool is helping to shift the way end-of-life and depression-related conversations are occurring between patients with multiple myeloma and their health care teams.